№2 / 2020

  1. ON THE POSSIBLE USE OF EXOGENOUS HISTONES AND CATIONIC PEPTIDES IN MOLECULAR BIOTECHNOLOGY
    Nozdrachev A.D., Goryukhina O.A., Martyushin S.V., Mishchenko I.V.
  2. PROTEASOME FUNCTIONING IN PRETUMORAL AND NEOPLASTIC HUMAN EPITHELIUM
    Sidenko E.A., Kakurina G.V., Cheremisina O.V., Shashova E.E., Kolegova E.S., Kondakova I.V.
  3. COMPUTATIONAL TOOLS AND METHODS FOR THE IMPLEMENTATION AND ELABORATION OF MOLECULAR DOCKING FOR ENZYMES OF THE MEDICAL DESTINATION
    Maksimenko A.V.
  4. MESENCHYMAL STEM CELL TRANSPLANTATION IN NEURODEREGENERATIVE DISEASES
    Mironova E.S., Linkova N.S., Popovich I.G.
  5. COLLAGEN EXCHANGE AND CONTENT OF MINERAL SUBSTANCES IN BONE TISSUE OF ANIMALS WITH EXPERIMENTAL DIABETES
    Savinova N.V., Danilova O.V., Butolin E.G., Vyatkin V.A.
  6. DETERMINATION OF FcγRIIIb (CD16) EXPRESSION ON THE SURFACE OF BLOOD NEUTROPHILS IN ANTI-PLAGUE VACCINATED PEOPLE
    Kravtsov A.L., Bugorkova S.A., Klyueva S.N., Kozhevnikov V.A., Kudryavtseva O.M.
  7. STRUCTURALLY FUNCTIONAL ORGANIZATION OF THE GENOME OF A CLINICALLY SIGNIFICANT STRAIN HELICOBACTER PYLORI HP42K ISOLATED FROM THE PATIENT A HOSPITAL IN THE BELARUS REPUBLIC
    Voropaev E.V., Baranov O.Yu., Valentovich L.N., Osipkina O.V., Zyatkov A.A., Bonda N.A., Voropaeva A.V., Platoshkin E.N., Mizura V.M., Shaforost A.S.
  8. IMMUNOHISTOCHEMICAL STUDY OF TRANSCRIPTION FACTORS NEUROD1, PROX1, FOXM1, SOMATOSTATIN, AND CXCR4 RECEPTORS, CD38 IN GLIOBLASTOMAS TO DEVELOP NEW APPROACHES FOR THE TARGETED THERAPY
    Galkovsky B.E., Mitrofanova L.B., Gulyaev D.A. Lakhina Y. S., Osipov Y.S.
  9. PROTECTIVE IMPACT OF BIOREGULATOR PEPTIDES BY EFFECT OF CONSTANT GEOMAGNETIC FIELD ON ORGANOTYPIC TISSUE CULTURE OF VARIOUS GENESIS
    Chalisova N.I., Rubinskii A.V., Vlasov T.D.
  10. ANALYSIS OF HERMINAL MUTATIONS IN ONCOGENES AND TUMOR SUPPRESSOR GENES IN WOMEN WITH MULTIPLE PRIMARY MALIGNANT NEOPLASMS
    Savkova A.V., Gerasimov A.V., Vasiliev G.V., Krasilnikov S.E., Gulyaeva L.F., Voitsitsky V.E.
  11. THE STATE OF THE PROTEOLYSIS SYSTEM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA ON THE BACKGROUND OF DIABETES MELLITUS TYPE 2
    Dyakov D.A., Akbasheva O.E., Zaitsevа A.A., Zavaruev I.S., Shuvalov I.Yu.